LEAP THERAPEUTICS, INC. Annual Earnings Per Share, Basic in USD/shares from 2017 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Leap Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2017 to 2023.
  • Leap Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.44 USD/shares, a 13.7% increase year-over-year.
  • Leap Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.79 USD/shares, a 88% increase year-over-year.
  • Leap Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -3.98 USD/shares, a 17.4% increase from 2022.
  • Leap Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -4.82 USD/shares, a 926% decline from 2021.
  • Leap Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -0.47 USD/shares, a 25.4% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4 +$0.84 +17.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 -$5 -$4 -926% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $0 +$0.16 +25.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 -$1 +$0.84 +57.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 -$1 +$0.17 +10.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$2 +$1.63 +49.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$3 Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.